An introduction to the role of angel investors in early-stage bioscience companies and a look at successful investment pathways in the sector.

A high-level exploration of biotech subfields and how different innovations—from biologics to digital tools—reach commercialization.

Guidance on how to evaluate biotech teams, technologies, and financial structures when considering early-stage investment.

An overview of regulatory frameworks that impact biotech startups and how these shape investment timelines and risks.

An investor-focused session featuring a select group of regional founders presenting science-based ventures seeking capital and strategic support.

We’re inviting a small group of new and seasoned investors to take part in a workshop designed to make life sciences investing in Kansas City clearer, easier, and more rewarding....

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A clear introduction to biotech as an investable asset class, grounded in both real-world impact and financial opportunity. You’ll understand how innovation moves from lab to market and where investors...

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A practical look at where angel investors play across the biotech lifecycle, from early proof-of-concept to value inflection points. Learn how capital, timing, and strategic support influence outcomes in a...

A breakdown of how drugs move from discovery to commercialization, including clinical development, manufacturing, and exit pathways. You’ll see where value is created, where risk accumulates, and what it takes...